台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.49%
  • 成交量
    55
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元富-中壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-中壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/14698.67598.00102.0011440.69%
2024/05/130.5107.0000.00107.000.51270.39%
2024/05/100117.0000.00118.5001200.03%
2024/04/250118.0000.00117.5001150.04%
2024/04/220116.0000.00116.0001140.04%
2024/04/180.1116.5000.00117.000.11120.05%
2024/04/150118.0000.00117.0001070.04%
2024/04/110.2119.5000.00119.500.21010.16%
2024/04/100.1126.6400.00127.000.1950.15%
2024/04/090.1124.0000.00124.000.1770.17%
2024/04/080123.5000.00123.500730.05%
2024/04/0300.001123.50123.50-171-1.40%
2024/03/260.1124.0000.00123.000.1630.16%
2024/03/250123.500.1124.50124.00-0.162-0.10%
2024/03/2200.000.2124.00122.50-0.260-0.33%
2024/03/200123.0000.00121.500560.07%
2024/03/1900.001121.50123.00-155-1.81%
2024/03/150122.0000.00121.500470.08%
2024/03/110115.0000.00114.500360.12%
2024/03/050112.5000.00113.500330.13%
2024/03/041.3112.5400.00112.501.3333.93%
2024/02/260112.5000.00112.000320.14%
2024/02/200113.0000.00112.500310.14%
2024/02/150111.5000.00112.000310.14%
2024/02/050112.0000.00112.500310.14%
2024/01/301110.5000.00110.001313.21%
2024/01/250111.0000.00110.500300.15%
2023/11/2100.000.1114.00113.50-0.120-0.28%
2023/10/2700.000.2116.50116.50-0.220-1.19%
2023/08/171110.5000.00110.501313.17%
2022/12/0800.001104.50105.00-138-2.60%
2022/12/0700.001101.50100.50-136-2.72%
2022/12/061101.5000.00102.001342.94%
2022/11/301100.0000.00100.001273.57%
2022/11/110101.0000.00100.500200.09%
2022/10/130105.5000.00104.000150.01%
2022/10/120102.5000.00104.500160.11%
2022/09/120109.0000.00107.500170.10%
2022/08/110113.5000.00113.000240.07%
2022/07/110102.0000.00100.500420.04%
2022/06/130101.5000.00100.000460.04%
2022/05/120109.0000.00109.000330.05%
2022/04/140127.0000.00126.000250.06%
2022/03/150125.0000.00125.000210.07%
2022/02/110129.0000.00128.000200.07%
2022/01/110125.5000.00125.500230.06%
2021/12/130125.5000.00125.500320.05%
2021/04/120151.5000.00150.500360.02%
2021/03/120132.5000.00133.000260.03%
2021/02/180123.5000.00124.000280.00%
2021/02/170123.5000.00123.500290.02%
2021/01/120122.0000.00123.000340.02%
2020/12/150121.0000.00121.000350.00%
2020/12/140123.5000.00123.500340.02%
2020/11/120118.0000.00119.000340.02%
2020/10/130113.5000.00113.000350.02%
2020/09/140112.0000.00111.500490.02%
2020/08/120108.0000.00108.000570.02%
2020/07/130108.5000.00107.000630.01%
2020/06/150111.5000.00111.500530.00%
2020/06/120110.5000.00110.000530.01%
2019/03/0400.000110.00110.00025-0.18%
2018/01/191129.001126.00124.0001480.00%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音